Clinical Trials on Schizophrenics in Canada

Total 248 results

Laval University

Completed

Modafinil as an Adjunctive on Cognitive Functioning in Patients With Schizophrenia

Schizophrenia and Schizophrenia Spectrum Psychosis

Canada
Centre for Addiction and Mental Health

Recruiting

Effects of NAC on Symptoms of CHR Patients

Prodromal Schizophrenia

Canada
University of Toronto
Ontario Shores Centre for Mental Health Sciences

Recruiting

tDCS and Executive Function Training for Schizophrenia

Schizophrenia | Schizophrenia and Related Disorders | Schizophrenia Spectrum Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

The Effects of Non-invasive Brain Stimulation on Treatment Adherence in Schizophrenia

Schizophrenia;Schizoaffective

Canada
The Royal Ottawa Mental Health Centre

Recruiting

Adjunctive Methylphenidate ER in Patients With Schizophrenia to Improve Functional and Cognitive Outcomes

Schizophrenia Schizoaffective

Canada
Queen's University
Walmart

Completed

Role of Nintendo Wii in Improving Negative Symptoms and Quality of Life in Chronic Schizophrenia

Chronic Schizophrenia

Canada
Centre de Recherche de l'Institut Universitaire...

Unknown

Investigator Initiated Study - Asenapine Early Psychosis

Disorders | Schizophrenia and Disorders With Psychotic Features

Canada
University of British Columbia

Completed

CARE Study: Improving Treatment for the Most Severely Ill With Schizophrenia

Psychosis, Schizophrenia

Canada
Centre for Addiction and Mental Health

Recruiting

"Extended" (Alternate Day) Antipsychotic Dosing

Drug Therapy | Schizophrenia and Related Disorders | Antipsychotic Agents | Drug Administration Schedule

Canada
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Recruiting

Topiramate and Schizophrenia: Effects on Weight and Psychopathology

Schizophrenia, Schizoaffective Disorder

Canada
University of Toronto
Ontario Shores Centre for Mental Health Sciences

Recruiting

EEG Outcomes From Cognitive Behavioural Therapy for Psychosis (EPIC)

Psychotic Disorders | Schizophrenia and Related Disorders

Canada
Centre for Addiction and Mental Health
University Health Network, Toronto; Schizophrenia Society of Ontario

Withdrawn

Deep Brain Stimulation (DBS) for the Management of Treatment Refractory Negative Symptoms in Schizophrenia

Schizophrenia; Negative Type

Canada
Centre for Addiction and Mental Health

Recruiting

Semaglutide in Comorbid Schizophrenia Spectrum Disorder and Obesity (Sema)

Schizophrenia Spectrum Disorders

Canada
University of Ottawa
The Ottawa Hospital

Unknown

Effects of CDP-Choline on Gating and Cognitive Deficits in First Episode Schizophrenia

First Episode Schizophrenia

Canada
Ciusss de L'Est de l'Île de Montréal
Canadian Institutes of Health Research (CIHR)

Recruiting

Comparaison of Avatar Therapy to Cognitive Behavioral Therapy in Schizophrenia With Treatment Refractory Hallucinations (Phase3)

Treatment-resistant Schizophrenia | Auditory Hallucination, Verbal

Canada
Lawson Health Research Institute
University of Western Ontario, Canada

Recruiting

Tracking Outcomes in Psychosis (TOPSY)

Schizophrenia

Canada
Centre for Addiction and Mental Health
Ontario Ministry of Health and Long Term Care

Completed

Virtual Rehabilitation for the Treatment of Motivational Deficits in Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health
Pfizer

Completed

Effects of Varenicline on Plasticity in Schizophrenia (VAR-PAS)

Schizophrenia

Canada
University of Ottawa

Unknown

Pilot Study Using an NMDA Antagonist to Modulate Transcranial Direct Current Stimulation (tDCS) Effects on Sensory Discrimination

Schizophrenia

Canada
Centre for Addiction and Mental Health
Janssen Inc.

Recruiting

Risk of Breakthrough Symptoms With Long-Acting Injectable Medications

Schizophrenia | Schizophrenia Relapse

Canada
The Royal Ottawa Mental Health Centre

Recruiting

Social Cognition in Youth Who Have a First Degree Relative With Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health
National Alliance for Research on Schizophrenia and Depression

Completed

Antipsychotic Medication Extended Dosing Study

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

The Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Working Memory

Schizophrenia

Canada
Centre for Addiction and Mental Health
Canadian Psychiatric Research Foundation

Completed

Antipsychotic Polypharmacy in Schizophrenia

Schizophrenia

Canada
Scion NeuroStim
Centre for Addiction and Mental Health

Not yet recruiting

Neuromodulation for Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health

Recruiting

The Effects of tDCS on Illness Awareness in Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health
National Alliance for Research on Schizophrenia and Depression; Canadian Institutes...

Active, not recruiting

Paired Associative Stimulation in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

A Study of Cognitive Adaptation Training in Inpatient Forensic Environments (finCAT)

Schizophrenia

Canada
Centre for Addiction and Mental Health
Canadian Institutes of Health Research (CIHR)

Active, not recruiting

Response to Clozapine in Treatment Resistant Schizophrenia: A Longitudinal Magnetic Resonance Spectroscopy Study

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

Cognitive Behavioral Social Skills Training for Patients With Late-Life Schizophrenia: a Pilot Study (CBSST)

Schizophrenia

Canada
St. Joseph's Healthcare Hamilton

Unknown

rTMS Treatment for Positive and Negative Symptoms of Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health

Terminated

Anticholinergic Burden in Schizophrenia

Psychotic Disorders | Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Delusional Disorder

Canada
Centre for Addiction and Mental Health

Recruiting

Does Abnormal Insulin Action in the Brain Underlie Cognitive and Metabolic Dysfunction in Schizophrenia

Healthy | Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

Reactivity of the Vestibular System to Caloric Vestibular Stimulation in Schizophrenia

Healthy | Schizophrenia

Canada
University of Alberta
Alberta Health services

Completed

L-arginine in Treatment as Usual in Schizophrenia

Schizophrenia

Canada
Centre for Addiction and Mental Health

Terminated

Effects of Acute Nicotine Treatment on Neuroplasticity and Memory in Patients With Schizophrenia (NIC-PAS)

Schizophrenia

Canada
Centre for Addiction and Mental Health

Completed

rTMS Effects on Smoking Cessation and Cognition in Schizophrenia

Schizophrenia | Cigarette Smoking

Canada
Centre for Addiction and Mental Health

Recruiting

Does tDCS Change Synaptic Density in the Brains of Patients With Schizophrenia

Schizophrenia | Schizoaffective

Canada
University of Calgary

Completed

A Trial of Cognitive Training in Schizophrenia

Schizophrenia

Canada
Corporation de Recherche en Neuropsycho Pharmacologie...

Unknown

Clinical Benefits of Seroquel XR in Anxiety Disorder

Schizophrenia | Anxiety

Canada
Centre for Addiction and Mental Health

Completed

Feasibility and Outcomes of a Digital Health Support for the Schizophrenia Spectrum

Schizophrenia Spectrum and Other Psychotic Disorders

Canada
University of Toronto
Ontario Shores Centre for Mental Health Sciences

Recruiting

Virtual Cognitive Behavioural Therapy for Psychosis

Psychotic Disorders | Schizophrenia

Canada
Queen's University

Active, not recruiting

Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis

Schizophrenia | Psychosis

Canada
Centre for Addiction and Mental Health
Pfizer

Completed

Effects of Varenicline on Smoking Lapse in Smokers With and Without Schizophrenia

Smoking | Schizophrenia | Craving

Canada
Centre for Addiction and Mental Health
National Alliance for Research on Schizophrenia and Depression; Canadian Institutes... and other collaborators

Completed

Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia

Refractory Schizophrenia

Canada
Douglas Mental Health University Institute

Recruiting

Cognitive Remediation for Social Cognition in Schizophrenia and Related Disorders (RC2S)

Schizophrenia | Cognitive Impairment | Psychosis

Canada
Centre for Addiction and Mental Health

Recruiting

Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
National Alliance for Research on Schizophrenia...

Completed

Cognitive Remediation and Functional Skills Training in Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
Centre for Addiction and Mental Health
Pfizer

Completed

Effect of Varenicline on Cognitive Function in Cigarette Smokers With Schizophrenia

Schizophrenia | Schizoaffective Disorder

Canada
Centre for Addiction and Mental Health
The Ian Douglas Bebensee Foundation

Completed

Switching Antipsychotics: Abrupt Discontinuation Versus Overlap

Schizophrenia | Schizoaffective Disorder

Canada

Clinical Trials on Schizophrenics in Canada

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Venezuela

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations